Abstract

Background- Breast conserving treatment (BCT) is the treatment of choice in early breast cancer. Despite years of observation it is still regarded as controversial – not in regard to the very idea; the controversy pertains rather to the way it is being performed by radiation oncologists and surgeons. There are no uniform indic-ations as far as the optimal surgery range is concerned (lumpectomy alone, lumpectomy with the macroscopic margin of 1cm, excision of the breast tissue block of a segment or a quadrant). BCT has produced survival equivalent to mastectomy in the treatment of patients with early-stage invasive breast carcinoma in several randomized Phase III clinical trials.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call